Tom L. Blundell

Papers

Total Citations

340

H-Index

About

Tom L. Blundell is a pioneering structural biologist whose work has fundamentally shaped the intersection of molecular structure and drug discovery. His research centers on the structural biology of proteins, particularly growth factors, hormones, and enzymes, and how their three-dimensional architectures inform therapeutic development. Blundell’s major contributions include elucidating the structures of insulin and its receptor, as well as pioneering the use of comparative modeling and bioinformatics to predict protein structures—a cornerstone of modern structural genomics. His landmark review, "Keynote review: Structural biology and drug discovery" (2005), with over 340 citations, remains a seminal reference for researchers leveraging crystallography and computational methods in pharmaceutical design. Beyond this, his work has been cited over 50,000 times, reflecting immense impact. A Fellow of the Royal Society and recipient of numerous international awards, Blundell has also mentored generations of scientists, fostering innovations in rational drug design and personalized medicine. His legacy endures in the tools and frameworks that accelerate the translation of molecular insights into life-saving therapies.